Trial Profile
Phase II Study Of Gleevec (Imatinib Mesylate Formerly Known As(STI571) (NSC 716051) In Patients With Colorectal Cancer Stage IV.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Imatinib (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 29 Aug 2005 New trial record.